Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles: 2011-2025

Historic Amortizatization of Intangibles for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to -$503,000.

  • Enanta Pharmaceuticals' Amortizatization of Intangibles fell 20.30% to $958,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$503,000, marking a year-over-year decrease of 144.20%. This contributed to the annual value of -$503,000 for FY2025, which is 144.20% down from last year.
  • As of FY2025, Enanta Pharmaceuticals' Amortizatization of Intangibles stood at -$503,000, which was down 144.20% from $1.1 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Amortizatization of Intangibles registered a high of $2.9 million during FY2023, and its lowest value of -$2.1 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $1.2 million, with a median of $1.1 million in 2024.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Amortizatization of Intangibles crashed by 596.05% in 2021 and then soared by 343.89% in 2023.
  • Enanta Pharmaceuticals' Amortizatization of Intangibles (Yearly) stood at -$2.1 million in 2021, then spiked by 44.66% to -$1.2 million in 2022, then surged by 343.89% to $2.9 million in 2023, then crashed by 60.15% to $1.1 million in 2024, then plummeted by 144.20% to -$503,000 in 2025.